Search

everythinglearnresearchcommunity

for

Search:↓

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Fibroblast behavior is key for skin structure and healing.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Intralesional triamcinolone effectively reduces pain and inflammation in hidradenitis suppurativa flares.

The 'Swiss cheese' pattern in scalp biopsies can indicate trichotillomania, not just alopecia areata.

Lymphocytes may hinder hair stem cells, causing hair loss without scarring.

A high fat lard diet may protect against skin fibrosis and affect hair growth.

The man was diagnosed with stage III multiple myeloma and treated to improve kidney function.

Tretinoin may be effective for treating Fox-Fordyce disease.

Long-term etretinate use may cause delayed wound healing and extra tissue growth after injury.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Scalp inflammation can cause multiple hairs to grow from one follicle.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

New findings suggest the protein linked to Birt–Hogg–Dubé syndrome is important in cell signaling and could affect treatment understanding.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Flexural follicular lichen planus is a rare skin condition affecting body folds.

The treatment combining laser and fetal fibroblasts effectively reduces scarring.

Two patients got Cushing's syndrome after treatment with Triamcinolone Acetonide for mouth fibrosis, but recovered after stopping the treatment.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Corticosteroids can reduce scarring in acne keloidalis by targeting specific cells.

A kidney transplant patient developed pink skin bumps with spiny centers on her face and limbs.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

A rare finger tumor was imaged, showing a unique pattern not seen before.